Capricor Therapeutics
CAPR
#5616
Rank
NZ$2.45 B
Marketcap
NZ$42.44
Share price
1.18%
Change (1 day)
160.75%
Change (1 year)

Capricor Therapeutics (CAPR) - Net assets

Net assets on the balance sheet as of March 2026 : NZ$0.49 Billion

According to Capricor Therapeutics 's latest financial reports the company has NZ$0.49 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Capricor Therapeutics - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2024-12-31$NZ$0.25 B621.69%
2023-12-31$NZ$35.73 M92.52%
2022-12-31$NZ$18.56 M-59.58%
2021-12-31$NZ$45.92 M17.5%
2020-12-31$NZ$39.08 M284.85%
2019-12-31$NZ$10.15 M47.58%
2018-12-31$NZ$6.88 M-56.47%
2017-12-31$NZ$15.8 M-373.53%
2016-12-31$-NZ$5.78 Million283.35%
2015-12-31$-NZ$1.51 Million-81.1%
2014-12-31$-NZ$7.98 Million1125.27%
2013-12-31$-NZ$0.66 Million-110.94%
2012-12-31$NZ$5.94 M458.97%
2011-12-31$NZ$1.06 M-68.38%
2010-12-31$NZ$3.36 M-18.02%
2009-12-31$NZ$4.1 M-53.31%
2008-12-31$NZ$8.79 M-55.68%
2007-12-31$NZ$19.84 M-10472.43%
2006-12-31$-NZ$0.2 Million68.45%
2005-12-31$-NZ$0.12 Million37.9%
2004-12-31$-NZ$0.09 Million31.58%
2003-12-31$-NZ$0.07 Million33.54%
2002-12-31$-NZ$0.05 Million117.65%
2001-12-31$-NZ$0.03 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$143.09 B 29,029.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$6.00 B 1,122.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.46 Billion-396.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$0.80 B 63.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$0.69 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$6.29 M-98.72%๐Ÿ‡บ๐Ÿ‡ธ USA